Word

ELAGORYN

Status

Pending

Status Code

688

Status Date

Tuesday, February 6, 2024

Serial Number

97774625

Mark Type

4000

Filing Date

Tuesday, January 31, 2023

Published for Opposition

Tuesday, December 12, 2023

Trademark Owner History

Glaxo Group Limited - Owner At Publication

Classifications

5 Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Trademark Events

Feb 6, 2024

Noa E-Mailed - Sou Required From Applicant

Dec 12, 2023

Official Gazette Publication Confirmation E-Mailed

Dec 12, 2023

Published For Opposition

Nov 22, 2023

Notification Of Notice Of Publication E-Mailed

Nov 3, 2023

Approved For Pub - Principal Register

Oct 30, 2023

Assigned To Examiner

Jul 12, 2023

Teas Change Of Correspondence Received

Jul 12, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Jul 12, 2023

Teas Change Of Owner Address Received

Feb 17, 2023

New Application Office Supplied Data Entered

Feb 3, 2023

New Application Entered